Synovis takes Veritas biomaterial to Canada:
This article was originally published in Clinica
Synovis Surgical Innovations has gained approval in Canada to market its implantable remodellable biomaterial for use in three applications - pelvic floor reconstruction, pelvic organ prolapse repair and as a sling for the treatment of stress urinary incontinence. The Veritas collagen matrix product is currently being assessed in studies at five US centres. Clinical data from the studies, so far, indicate that the implant is efficacious in the approved applications, with no infections, rejections or erosion of the implanted tissue, said the St Paul, Minnesota firm, a division of Synovis Life Technologies. The Veritas implant is already cleared in the US for the same applications.